Lilly tests the efficacy of Tirzepatide-a novel dual GIP, GLP-1 agonist Eli Lilly is planning to test its diabetes drug Tirzepatide in a phase 2b Non-Alcoholic…
Phone
India: +91-11-45689769, +91-9650213330Address
New Delhi-110075, IndiaAddress
304 S. Jones Blvd #2432, Las Vegas NV 89107Phone
Outside India: +1(919)321-6187
